Edition:
United Kingdom

People: Novavax Inc (NVAX.OQ)

NVAX.OQ on NASDAQ Stock Exchange Global Select Market

6.24USD
23 Aug 2019
Change (% chg)

$-0.40 (-5.96%)
Prev Close
$6.63
Open
$6.53
Day's High
$6.53
Day's Low
$6.06
Volume
98,273
Avg. Vol
201,595
52-wk High
$51.60
52-wk Low
$4.01

Lichaa, Jody 

Ms. Jody Lichaa is Senior Vice President - Quality Assurance of the Company. Ms. Lichaa joined Novavax in October 2011 as Director, Quality Assurance. She was named Executive Director, Quality Assurance in August 2013 and then named Vice President, Quality Assurance in October 2015. Her role has recently expanded to include quality assurance validation, clinical quality assurance, and quality assurance globally. Ms. Lichaa will continue to serve as the strategic leader and operational manager to direct, oversee, and manage all quality assurance activities. She has more than 20 years of experience in quality, primarily in vaccine development. Prior to joining Novavax, Ms. Lichaa was most recently the Senior Director, Quality for PharmAthene, where she managed global quality assurance and quality control activities. She previously held positions of increasing responsibility at Shire and Baxter. Ms. Lichaa received her Bachelor of Science degree in Toxicology from Northeastern University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

James Young

471,715

Stanley Erck

4,158,400

John Trizzino

1,329,780

Gregory Glenn

1,681,460

John Herrmann

1,137,580

Jody Lichaa

--
As Of  31 Dec 2018